Article Versions Notes

Barré T, Bourlière M, Ramier C, Carrat F, Di Beo V, Protopopescu C, Marcellin F, Bureau M, Cagnot C, Dorival C, et al. Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort). Journal of Clinical Medicine. 2022; 11(20):6135. https://doi.org/10.3390/jcm11206135

Barré, Tangui, Marc Bourlière, Clémence Ramier, Fabrice Carrat, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Carole Cagnot, Céline Dorival, and et al. 2022. "Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)" Journal of Clinical Medicine 11, no. 20: 6135. https://doi.org/10.3390/jcm11206135

Barré, T., Bourlière, M., Ramier, C., Carrat, F., Di Beo, V., Protopopescu, C., Marcellin, F., Bureau, M., Cagnot, C., Dorival, C., Zoulim, F., Zucman-Rossi, J., Duclos-Vallée, J.-C., Fontaine, H., Carrieri, P., & the ANRS/AFEF Hepather Study Group. (2022). Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort). Journal of Clinical Medicine, 11(20), 6135. https://doi.org/10.3390/jcm11206135